Thyroid Hormone Receptor Interactor 4 (TRIP4) (Middle Region) Peptid
Kurzübersicht für Thyroid Hormone Receptor Interactor 4 (TRIP4) (Middle Region) Peptid (ABIN8113872)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- TRIP4 Peptide - middle region
-
Sequenz
- FKKDEILDGQ KSGDHLKRGR KKGRNRQEVP AFTEPDTTAE VKTPFDLAKA
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- TRIP4 Antibody (ARP85792_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- TRIP4 (Thyroid Hormone Receptor Interactor 4 (TRIP4))
-
Hintergrund
-
Background Information: This gene encodes a subunit of the tetrameric nuclear activating signal cointegrator 1 (ASC-1) complex, which associates with transcriptional coactivators, nuclear receptors and basal transcription factors to facilitate nuclear receptors-mediated transcription. This protein is localized in the nucleus and contains an E1A-type zinc finger domain, which mediates interaction with transcriptional coactivators and ligand-bound nuclear receptors, such as thyroid hormone receptor and retinoid X receptor alpha, but not glucocorticoid receptor. Mutations in this gene are associated with spinal muscular atrophy with congenital bone fractures-1 (SMABF1).
Alternative Symbols: ASC1, ASC-1, ZC2HC5, HsT17391
-
Molekulargewicht
- 63 kDa
-
Gen-ID
- 9325
-
NCBI Accession
- NP_057297
-
UniProt
- Q15650
Target
-
